News

Booklet Label Market Strict FDA norms, rising drug info needs, and digital tracking trends drive strong growth in the USA pharmaceutical bo ...
Retail chatter around Moleculin Biotech surged on Monday after the company said the European Medicines Agency had approved ...
The global helicobacter pylori testing market is poised for significant growth, with projections estimating a market value of USD 380.3 million by 2032. Marking a substantial leap from its 2022 ...
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
Q2 2025 Earnings Conference Call May 12, 2025 4:30 PM ET. Company Participants. Vincent Anzalone - Vice President of Investor Relatio ...
Hold off on inoculating people ages 60 and older against chikungunya infection with the Ixchiq vaccine, the FDA and CDC ...
Antibiotic use in the first 3 month of life was associated with a 23% increase in risk of early puberty in girls.
In a statement today, the company said it supports recent precautionary measures and that thorough investigations are needed ...
New research reveals the potential of drugs that have been on the market for decades to treat diseases other than those for ...
Reports of severe adverse events in some people who received the chikungunya vaccine have spurred regulators in Europe and ...
THE001, a thermosensitive doxorubicin liposome for soft tissue sarcomas, received FDA orphan drug designation, offering ...
The findings show access to Tofersen, the first effective new motor neurone disease (MND) treatment for decades, has become a ...